WENTWORTH KORY JAMES (Chief Financial Officer) sold 7.5% of their position (8.91K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $88.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2025ACC: 0001725663-25-000004
Officer· Chief Financial Officer
Since Oct 2021
-8.91K
Net shares
Net seller
$88.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.91K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.91K
Price / share
$9.98
Trade value
$88.93K
% of position
7.5%
11/21/2025
118.94K→110.03K
Total
Net shares
−8.91K
Net value
-$88.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/21/2025 | S · Sale | −8.91K | $9.98 | $88.93K | 7.5% | 118.94K | 110.03K |
| Total | −8.91K | -$88.93K | ||||||
Derivative Transactions0
No derivative transactions reported